Stock CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Corbus Pharmaceuticals Holdings, Inc.

Equities

CRBP

US21833P3010

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
48.55 USD +7.89% Intraday chart for Corbus Pharmaceuticals Holdings, Inc. +13.25% +703.81%
May. 13 RBC Initiates Corbus Pharmaceuticals Holdings at Outperform With Speculative Risk Qualifier, $77 Price Target MT
May. 08 Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $60 From $58, Maintains Outperform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CORBUS PHARMACEUTICALS HOLDINGS, INC. Stock Corbus Pharmaceuticals Holdings, Inc.
 510M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 22.31B -
ARGENX SE Stock argenx SE
 21.6B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 18.23B -
  1. Stock Market
  2. Equities
  3. CRBP Stock
  4. Charts Corbus Pharmaceuticals Holdings, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW